Dhrita Khatri
Dhrita Khatri
Dhrita Khatri is a pharmacist and researcher with experience in hospital settings in Melbourne, Australia, and Auckland/Wellington, New Zealand. She joined the Murdoch Children's Research Institute (MCRI) in early 2023 as part of the Cancer Therapies Group. Her focus is on applying pharmacogenomics to enhance paediatric care. Through her collaborations with MCRI, the Royal Children's Hospital, Clinical Pharmacogenetics Implementation Consortium, the University of Melbourne, the Victorian Paediatric Cancer Centre, and reNEW, Dhrita's research has a strong translational aspect, aiming to improve clinical practices.
Dhrita Khatri is a pharmacist and researcher with experience in hospital settings in Melbourne, Australia, and Auckland/Wellington, New Zealand. She joined the Murdoch Children's Research Institute (MCRI) in early 2023 as part of the Cancer Therapies...
Dhrita Khatri is a pharmacist and researcher with experience in hospital settings in Melbourne, Australia, and Auckland/Wellington, New Zealand. She joined the Murdoch Children's Research Institute (MCRI) in early 2023 as part of the Cancer Therapies Group. Her focus is on applying pharmacogenomics to enhance paediatric care. Through her collaborations with MCRI, the Royal Children's Hospital, Clinical Pharmacogenetics Implementation Consortium, the University of Melbourne, the Victorian Paediatric Cancer Centre, and reNEW, Dhrita's research has a strong translational aspect, aiming to improve clinical practices.
Top Publications
- Khatri, D, Felmingham, B, Moore, C, Lazarakis, S, Stenta, T, Collier, L, Elliott, D, Metz, D, Conyers, R. Genotype Informed Bayesian Dosing of Tacrolimus in Paediatric Solid Organ Transplant Individuals. 2026 view publication
- Conyers, R, Stenta, T, Felmingham, B, Somogyi, A, Kirkpatrick, C, Halman, A, Moore, C, Khatri, D, Williams, E, Dyas, R, et al. Protocol for a prospective feasibility study investigating phenoconversion of CYP3A4, CYP2C19 and CYP2D6 genotypes in paediatric and adolescent and young adult patients with an acute diagnosis of Hodgkin or Non-Hodgkin Lymphoma [PEGASUS]. 2026 view publication
- Khatri, D, Halman, A, Kausman, J, Mathew, J, Bannister, E, Stenta, T, Moore, C, Williams, E, Dyas, R, Stolper, J, et al. Protocol for Bayesian combined multi-genotype and concentration informed tacrolimus dosing in paediatric solid organ transplantation (BRUNO-PIC). 2026 view publication
- Moore, C, Halman, A, Stenta, T, Khatri, D, Williams, E, Dyas, R, Stolper, J, Elliott, DA, Conyers, R. Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort.. Clin Transl Sci 18(5) : e70246 2025 view publication
- Conyers, R, Stenta, T, Somogyi, AA, Kirkpatrick, C, Halman, A, Wang, S, Moore, C, Khatri, D, Williams, E, Dyas, R, et al. Phenoconversion of CYP3A4, CYP2C19 and CYP2D6 in Pediatrics, Adolescents and Young Adults With Lymphoma: Rationale and Design of the PEGASUS Study.. Clin Transl Sci 18(4) : e70209 2025 view publication
Page 1 of 2
Career information
Share //
